Surajit Kumar Ghosh

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition

Prashant Gahtori, Surajit Kumar Ghosh, Pratap Parida et al. · Experimental Parasitology · 2012 · 68 citations

Medicinal Chemistry, Potential Antifolate Lead, Antiparasitic Agent +9

Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4‐aminoquinoline‐1,3,5‐triazine derivatives

Hans Raj Bhat, Anup Masih, Anshul Shakya et al. · Journal of Heterocyclic Chemistry · 2019 · 62 citations

Bioorganic Chemistry, Antifungal Evaluation, Escherichia Coli +21

In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor

Supriya Sahu, Surajit Kumar Ghosh, Prashant Gahtori et al. · Pharmacological Reports · 2019 · 59 citations

Medicinal Chemistry, Pf-dhfr Inhibitor, Antifungal Agent +10

4-Aminoquinoline-1,3,5-triazine: Design, synthesis, in vitro antimalarial activity and docking studies

Hans Raj Bhat, Udaya Pratap Singh, Prashant Gahtori et al. · New Journal of Chemistry · 2013 · 57 citations

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +15